Finance

Lists
Why is PRE down 8,11%?
Dive Deeper
PRE:NASDAQ
Prenetics Global Ltd
20,17 $
-8,11%
(-1,78) 1D
20,17 $
0,00% (0,00)
After hours
Closed: 2 қаз., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRE...
Open
22,15 $
High
22,22 $
Low
19,85 $
Mkt. cap
345,78 млн
Avg. vol.
249,30 м.
Volume
311,53 м.
52-wk high
27,24 $
52-wk low
11,36 $
EPS
-2,88 $
Beta
0,40
Shares outstanding
15,56 млн
No. of employees
98
Open
22,15 $
High
22,22 $
Low
19,85 $
Mkt. cap
345,78 млн
Avg. vol.
249,30 м.
Volume
311,53 м.
52-wk high
27,24 $
52-wk low
11,36 $
EPS
-2,88 $
Beta
0,40
Shares outstanding
15,56 млн
No. of employees
98
News stories
From web sources and news partners
Profile
Prenetics is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer. Its subsidiary brands include CircleDNA, Insighta and IM8. Wikipedia
About Prenetics Global Ltd
CEO-
Employees98
Founded2014
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 5 analysts giving stock ratings to PRE in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PRE in the last 3 months.
Highest
Current 20,17 $
40,00 $ (+98,31%)
Average
37,00 $ (+83,44%)
Lowest
35,00 $ (+73,53%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eric Des Lauriers
Craig-Hallum
Buy
Maintained
-
-
09/22/2026
Unknown Analyst
StoneX
Buy
Reiterated
40,00 $
+98,3%
09/08/2026
Jeff Van Sinderen
B. Riley Securities
Buy
Initiated
37,00 $
+83,4%
08/27/2026
Ryan Meyers
Lake Street
Buy
Reiterated
35,00 $
+73,5%
08/19/2026
George Kelly
Roth MKM
Buy
Maintained
36,00 $
+78,5%
08/19/2026
Bill Sutherland
Benchmark Co.
Buy
Maintained
40,00 $
+98,3%
07/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
23,56 млн
36,56 млн
35,95 млн
46,49 млн
Cost of goods sold
9,53 млн
14,97 млн
12,67 млн
16,28 млн
Cost of revenue
9,53 млн
14,97 млн
12,67 млн
16,28 млн
Research and development expenses
1,17 млн
743,00 м.
1,44 млн
757,00 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,41 млн
34,13 млн
31,55 млн
51,36 млн
Operating expense
20,19 млн
35,17 млн
32,15 млн
51,18 млн
Total operating expenses
29,72 млн
50,14 млн
44,82 млн
67,47 млн
Operating income
-6,16 млн
-13,58 млн
-8,87 млн
-20,98 млн
Other non operating income
96,00 мың
9,59 млн
-17,86 млн
9,28 млн
EBT including unusual items
-6,78 млн
-9,66 млн
-27,31 млн
-9,08 млн
EBT excluding unusual items
-6,78 млн
-3,87 млн
-26,74 млн
-11,71 млн
Income tax expense
9,00 мың
38,00 мың
28,00 мың
5,00 мың
Effective tax rate
-0,13%
-0,39%
-0,10%
-0,06%
Other operating expenses
-395,00 м.
297,00 м.
-840,00 м.
-941,00 м.
Net income
-7,41 млн
-7,50 млн
-23,10 млн
-8,98 млн
Net profit margin
-31,45%
-20,52%
-64,26%
-19,32%
Earnings per share
-
-0,19
-
-0,52
Interest and investment income
-
1,20 млн
-
-
Interest expense
-55,00 мың
-45,00 мың
-9,00 мың
-13,00 мың
Net interest expenses
-55,00 мың
1,15 млн
-9,00 мың
-13,00 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,33 млн
-13,34 млн
-8,71 млн
-20,80 млн
Gain or loss from assets sale
-
-
-253,00 м.
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары